PGT-SR (Preimplantation Genetic Testing for Chromosomal Structural Rearrangements)

PGT‑SR (Preimplantation Genetic Testing for Structural Chromosomal Rearrangements) is a solution aimed at the analysis of structural chromosomal rearrangements in embryos. According to the product literature, it is based on single‑cell whole‑genome amplification and NGS sequencing to detect embryos from patients with chromosomal abnormalities and select euploid embryos for transfer, with the aim of reducing the risk of offspring affected by chromosomal disease.

Detailed Description

Principle of operation

It relies on exclusive single‑cell whole‑genome amplification technology and NGS sequencing. It uses WGS through ChromInst® as its technical principle, and analysis is performed using the ChromGo® platform.

PGT-SR principle of operation

Clinical applications and benefits

Allows the study of structural chromosomal alterations in embryos, including duplications, deletions, translocations, Robertsonian translocations and inversions.
PGT-SR clinical applications
Allows the selection of euploid embryos for transfer in patients with chromosomal abnormalities, with the aim of reducing the risk of children affected by chromosomal disease. Detection of aneuploidy, sex, mosaicism from 20% to 70%, sibling relationship checking and triploidy/UPD (uniparental disomy).
PGT-SR benefits

Key Features

Based on single‑cell whole‑genome amplification and NGS sequencing for embryonic analysis. Aimed at the study of structural chromosomal rearrangements such as duplications, deletions, translocations, Robertsonian translocations and inversions. It is necessary to analyse the karyotype of the parents. Integration with ChromGo® software for data interpretation. Greater efficiency in each sequencing run thanks to the ability to multiplex with other Yikon product line products.

Presentation Details

Kit configurations: WGA ChromInst / ChromSwift and XK-008/XK-013 or XK-038/-048 libraries Sequencing requirements: 1M reads (4 Mb) and 4.5M reads (1 Mb), with SE55 read length.
×

Area:

Molecular Genetics, Preimplantation genetic diagnosis, Reproduction
Consult our experts

Google reCaptcha: Invalid site key.

Related products

SureSelect Cancer CGP Assay

Targeted-enrichment NGS pan-cancer panel for comprehensive genomic profiling (CGP) of solid tumours. Designed to detect somatic variants at DNA level (SNVs, indels, CNVs, translocations) and RNA level (gene fusions), as well as to assess complex immuno-oncology biomarkers such as tumour mutational burden (TMB), microsatellite instability (MSI) and homologous recombination deficiency (HRD). Detailed Description Operating principle…
Agilent
Next Generation Sequencing (NGS)

SeqOne HRD Solution con Agilent SureSelect CD HRR17 Panel

HRD analysis solution combining low-coverage whole-genome sequencing (shallow/low-pass WGS) and a targeted gene panel to detect genomic instability, BRCA1/2 alterations and other genes related to homologous recombination. It is designed for laboratories wishing to implement HRD testing in-house with an automated, efficient and clinically validated workflow. Detailed Description SeqOne’s HRD solution combines shallow WGS and…
Agilent
Next Generation Sequencing (NGS)

OncoSELECT®

Comprehensive targeted liquid biopsy assay designed to support decision-making in oncology through the analysis of 74 clinically relevant genes. The solution encompasses everything from library preparation reagents to bioinformatics analysis, clinical interpretation and the generation of detailed reports. 3.- Detailed Description Operating principle OncoSELECT® is an advanced liquid biopsy panel based on circulating cell-free DNA…
OncoDNA
Next Generation Sequencing (NGS)

Agilent SureSelect Human All Exon V8.

High-performance exome for the enrichment of human coding regions, with updated coverage of RefSeq, CCDS and GENCODE, including the TERT promoter and difficult-to-capture exons. 3.- Detailed Description Operating principle SureSelect Human All Exon V8 is based on NGS library preparation and capture enrichment of target regions of the human exome. The workflow is compatible with…
Agilent
Next Generation Sequencing (NGS)